Page last updated: 2024-11-07

3,4,6-tri-o-acetylglucal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4,6-tri-o-acetylglucal is a synthetic derivative of glucal, a naturally occurring sugar. It is synthesized by acetylation of glucal, typically using acetic anhydride and a base catalyst. 3,4,6-tri-o-acetylglucal is a versatile building block in organic synthesis, particularly for the preparation of glycosides and other carbohydrate derivatives. It has been studied extensively for its potential applications in medicinal chemistry and carbohydrate chemistry. For example, it has been used in the synthesis of antiviral agents, anti-inflammatory drugs, and carbohydrate mimetics. The compound's unique reactivity and structural features make it a valuable tool for exploring the synthesis of novel carbohydrate-based molecules.'

3,4,6-tri-O-acetylglucal: RN given refers to (D)-isomer with unspecified acetate locants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102891
SCHEMBL ID12083311
MeSH IDM0127571

Synonyms (33)

Synonym
d-arabino-hex-1-enitol, 1,5-anhydro-2-deoxy-, triacetate
LS-14102
nsc66181
nsc-66181
nsc287428
nsc-287428
(3,4-diacetyloxy-3,4-dihydro-2h-pyran-2-yl)methyl acetate
d-glucal triacetate
einecs 223-859-5
3,4,6-tri-o-acetylglucal
2,6-anhydro-5-deoxy-d-arabino-hex-5-enitol triacetate
1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol triacetate
einecs 220-709-0
FT-0624544
FT-0634522
AM84889
tri-o-acetylglucal
SY009244
mfcd00063253
SCHEMBL12083311
d-arabino-hex-1-enopyranose, 1,2-dideoxy-, triacetate
LLPWGHLVUPBSLP-UHFFFAOYSA-N
tri-o-acetyl-l-glucal
1,3,4-tri-o-acetyl-2,6-anhydro-5-deoxyhex-5-enitol
AKOS030212726
mfcd00064092
SY017625
FT-0773735
d-arabino-hex-1-enitol, 1,5-anhydro-2-deoxy-, 3,4,6-triacetate
1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol3,4,6-tri-o-acetyl
DTXSID90863045
2-(acetoxymethyl)-3,4-dihydro-2h-pyran-3,4-diyl (2r,3s,4s)-diacetate
SY356451
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.85 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]